sb 203580 has been researched along with rhodamine 123 in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (rhodamine 123) | Trials (rhodamine 123) | Recent Studies (post-2010) (rhodamine 123) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 1,760 | 10 | 424 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chai, D; Chen, Y; Wang, Y; Yang, R; Yuan, J; Zeng, Y; Zhou, Y; Zhu, X | 1 |
1 other study(ies) available for sb 203580 and rhodamine 123
Article | Year |
---|---|
Total Saponins from Paris forrestii Reverse Multidrug Resistance of MCF-7/ADM Cells by Suppression of P-gp via ERK Signaling Pathway.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Butadienes; Cell Line, Tumor; Doxorubicin; Drug Resistance, Multiple; Female; Humans; Imidazoles; MAP Kinase Signaling System; MCF-7 Cells; Melanthiaceae; Nitriles; Pyridines; Rhodamine 123; Saponins | 2020 |